The potential bidirectional relationship between long COVID and menstruation.

The potential bidirectional relationship between long COVID and menstruation.

Publication date: Sep 16, 2025

Women have reported menstrual changes following SARS-CoV-2 infection and variation in long COVID symptoms across the menstrual cycle. We examined (i) whether COVID is linked to abnormal uterine bleeding (AUB), (ii) if long COVID symptoms vary with the menstrual cycle, and (iii) potential underlying mechanisms. Here we show long COVID was associated with AUB in a UK population. When compared to those never infected (n = 9423), long COVID participants (n = 1048) reported increased menstrual volume, duration and intermenstrual bleeding, while those who recovered from acute COVID (n = 1,716) reported minimal menstrual disruption. Long COVID symptoms examined in 54 women across the menstrual cycle revealed that severity was highest during the perimenstrual and proliferative phases. Serum and endometrial analysis revealed higher serum 5α-dihydrotestosterone and lower endometrial androgen receptors in long COVID versus no COVID. Other ovarian hormones showed no significant differences. Serum cytokine profiling indicated increased menstrual inflammation with long COVID and immune cell aggregates were observed in menstrual endometrium. In conclusion, long COVID was associated with AUB but not impaired ovarian function. Differences in peripheral and endometrial inflammation may contribute to AUB and long COVID symptom severity. We anticipate our findings will instigate exploration of new therapeutic strategies for women with long COVID.

Open Access PDF

Concepts Keywords
Covid Adult
Endometrial COVID-19
Menstrual Cytokines
Women Cytokines
Endometrium
Female
Humans
Menstrual Cycle
Menstruation
Menstruation Disturbances
Middle Aged
Post-Acute COVID-19 Syndrome
SARS-CoV-2
United Kingdom
Young Adult

Semantics

Type Source Name
disease MESH long COVID
disease MESH SARS-CoV-2 infection
pathway REACTOME SARS-CoV-2 Infection
disease MESH uterine bleeding
disease MESH intermenstrual bleeding
drug DRUGBANK Stanolone
disease MESH inflammation
disease IDO cell
disease IDO symptom
disease MESH bleeding
disease IDO production
drug DRUGBANK Aspartame
disease MESH heavy menstrual bleeding
disease IDO blood
disease IDO facility
disease MESH iron deficiency anemia
disease MESH infection
disease MESH lifestyle
disease MESH sequelae
disease IDO process
disease IDO history
disease MESH symptom clusters
disease IDO susceptibility
disease IDO host
disease MESH causes
disease MESH Polyps
disease MESH Adenomyosis
disease MESH Leiomyomas
disease MESH Malignancy
drug DRUGBANK Coenzyme M
disease MESH endometriosis
disease MESH polycystic ovary syndrome
disease MESH AIDS
drug DRUGBANK Methylergometrine
disease MESH eating disorders
disease MESH interstitial cystitis
disease MESH obesity
drug DRUGBANK Pentaerythritol tetranitrate
drug DRUGBANK Copper
disease MESH overweight
pathway REACTOME S Phase
pathway REACTOME M Phase
disease MESH brain fog
disease MESH sore throat
disease MESH breathlessness
disease MESH Underweight
disease MESH Menstruation Disturbances

Original Article

(Visited 8 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *